Yahoo
NSE - Delayed Quote INR

Cipla Limited (CIPLA.NS)

1,378.90 +20.90 (+1.54%)
At close: October 30 at 3:28:21 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
Name Title Pay Exercised Year Born
Mr. Achin Gupta
MD, Global CEO & Director -- -- 1976
Mr. Sushrut Kulkarni
President & Global Chief Integrated Product Development -- -- 1970
Mr. Ashish Adukia
Global Chief Financial Officer -- -- --
Mr. Dinesh Ramniranjan Jain
Senior VP & Head of Corporate Finance -- -- --
Ms. Sneha Hiranandani B Com
Global Chief Information Officer -- -- --
Ms. Diksha Maheshwari
Head of Investor Relations -- -- --
Mr. Rajendra Kumar Chopra
Compliance Officer & Company Secretary 15.3M -- --
Ms. Meera Vanjari
Global Chief General Counsel -- -- --
Ms. Heena Kanal
Chief of Corporate Communication -- -- --
Mr. Arun Kakatkar
Global Chief People Officer -- -- --

Cipla Limited

Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai, 400013
India
91 22 2482 6000 https://www.cipla.com
Sector: 
Healthcare
Full Time Employees: 
31,369

Description

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Corporate Governance

Cipla Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 21, 2027 at 10:00 AM UTC

Cipla Limited Earnings Date

Recent Events

June 5, 2026 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: